pa旗舰厅
中
繁
EN
pa旗舰厅:For Patients
pa旗舰厅:Investors
Careers
Contact
Home
About Us
pa旗舰厅:Our Story
pa旗舰厅:Leadership
pa旗舰厅:Board of Directors
pa旗舰厅:Jacobio people stories
pa旗舰厅:Platform & Pipeline
Platform
Pipeline
pa旗舰厅:Publications
pa旗舰厅:Partnership
News
pa旗舰厅:Company News
pa旗舰厅:Media Report
Company News
76
press releases in total
2025
May 22, 2025
Jacobio’s KRAS G12C Inhibitor Glecirasib Approved for Market Launch
pa旗舰厅: [More]
May 9, 2025
SHP2 Inhibitor Sitneprotafib Combination Therapy Data Published in Academic Journal
pa旗舰厅: [More]
Mar 20, 2025
Jacobio Pharma Announces 2024 Annual Results
pa旗舰厅: [More]
Jan 7, 2025
The Registrational Clinical Data of Glecirasib was Published in Nature Medicine
pa旗舰厅: [More]
2024
Dec 10, 2024
Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH
pa旗舰厅: [More]
Nov 25, 2024
Jacobio Pharma Completes First Patient Dosage of Pan-KRAS Inhibitor
pa旗舰厅: [More]
Oct 21, 2024
Glecirasib Pancreatic Cancer Indication Received Orphan Drug Designation from EMA
pa旗舰厅: [More]
Oct 9, 2024
Jacobio Presents Pre-clinical Data of SHP2 plus KRAS G12C
pa旗舰厅: [More]
Oct 3, 2024
Jacobio Pharma to Present BET Inhibitor Data at 2024 ASH
pa旗舰厅: [More]
Sep 27, 2024
Jacobio Received RMB 172 million Payment
pa旗舰厅: [More]
Sep 26, 2024
Jacobio Pharma Received Pan-KRAS Inhibitor IND Approval from China CDE
pa旗舰厅: [More]
Sep 20, 2024
Jacobio Pharma Received Pan-KRAS Inhibitor IND Approval from FDA
pa旗舰厅: [More]
Sep 15, 2024
Jacobio Pharma Presents Efficacy Data of Glecirasib in Combination with JAB-3312 with PD-L1 Expression Levels
pa旗舰厅: [More]
Aug 30, 2024
Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor JAB-3312 to Allist in China
pa旗舰厅: [More]
Aug 12, 2024
Jacobio’s SHP2 Inhibitor JAB-3312 Published in Journal of Medicinal Chemistry
pa旗舰厅: [More]
Aug 7, 2024
Jacobio Completes First Patient Dosage in the Phase III Clinical Trial of JAB-3312 in Combination with Glecirasib
pa旗舰厅: [More]
Jul 26, 2024
Jacobio Completes First Patient Dosage of p53 Y220C Activator
pa旗舰厅: [More]
Jul 15, 2024
Jacobio Appoints Dr. Michael Ren as Vice President of Chemistry
pa旗舰厅: [More]
Jun 13, 2024
Jacobio Appoints Dr. Alan Xiao as Vice President of Clinical Pharmacology
pa旗舰厅: [More]
Jun 2, 2024
Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
pa旗舰厅: [More]
Pages
1
2
3
4
›
»
